These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33404683)

  • 1. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child's genetic risk.
    Johnson SB; Lynch KF; Roth R; Lundgren M; Parikh HM; Akolkar B; Hagopian W; Krischer J; Rewers M; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetologia; 2021 Mar; 64(3):591-602. PubMed ID: 33404683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
    Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
    Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies.
    Lynch KF; Lee HS; Törn C; Vehik K; Krischer JP; Larsson HE; Haller MJ; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Hyöty H; Bonifacio E; Lernmark Å;
    J Autoimmun; 2018 Jan; 86():93-103. PubMed ID: 28941965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study.
    Silvis K; Aronsson CA; Liu X; Uusitalo U; Yang J; Tamura R; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler A; Akolkar B; Krischer J; Virtanen SM; Norris JM;
    Pediatr Diabetes; 2019 Feb; 20(1):86-92. PubMed ID: 30411443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
    Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
    Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.
    Krischer JP; Lynch KF; Schatz DA; Ilonen J; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Bonifacio E;
    Diabetologia; 2015 May; 58(5):980-7. PubMed ID: 25660258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
    Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
    Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
    Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
    J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.
    Krischer JP; Lynch KF; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
    Diabetes Care; 2017 Sep; 40(9):1194-1202. PubMed ID: 28646072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.
    Kemppainen KM; Vehik K; Lynch KF; Larsson HE; Canepa RJ; Simell V; Koletzko S; Liu E; Simell OG; Toppari J; Ziegler AG; Rewers MJ; Lernmark Å; Hagopian WA; She JX; Akolkar B; Schatz DA; Atkinson MA; Blaser MJ; Krischer JP; Hyöty H; Agardh D; Triplett EW;
    JAMA Pediatr; 2017 Dec; 171(12):1217-1225. PubMed ID: 29052687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study.
    Uusitalo U; Liu X; Yang J; Aronsson CA; Hummel S; Butterworth M; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler AG; Akolkar B; Krischer J; Norris JM; Virtanen SM;
    JAMA Pediatr; 2016 Jan; 170(1):20-8. PubMed ID: 26552054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: The TEDDY Study.
    Li Q; Liu X; Yang J; Erlund I; Lernmark Å; Hagopian W; Rewers M; She JX; Toppari J; Ziegler AG; Akolkar B; Krischer JP;
    Diabetes; 2021 Jan; 70(1):282-292. PubMed ID: 33106256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.